$DCTH SEC Filings

Filed On	Filing
19 Oct 2026	SCHEDULE 13D/A
14 Oct 2026	Form 4: Rosalind Advisors, Inc., Director and 2 others Received 3,627 shares by conversion · Disposed of 27,502 shares (Other Transaction)
14 Aug 2026	S-8
14 Aug 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	SCHEDULE 13G
14 May 2026	Form 4: Sylvester John Richard, Director Granted 22,500 Stock Option (right to buy)
14 May 2026	Form 4: Martell Bridget A, Director Granted 22,500 Stock Option (right to buy)
14 May 2026	Form 4: Czerepak Elizabeth, Director Granted 22,500 Stock Option (right to buy)
14 May 2026	Form 4: Salamon Steven A J, Director Granted 22,500 Stock Option (right to buy)
14 May 2026	Form 4: Aharon Gil, Director Granted 22,500 Stock Option (right to buy)
14 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
07 May 2026	10-Q
07 May 2026	8-K: Results of Operations and Financial Condition
27 Apr 2026	SCHEDULE 13G/A
02 Apr 2026	ARS
02 Apr 2026	DEFA14A
02 Apr 2026	Proxy statement: annual meeting on May 13, 2026 CEO pay $5.8M, up 167% · say-on-pay vote
20 Mar 2026	SCHEDULE 13G

Comments